Apollo Hospitals Enterprise share news and announcements
NSE: APOLLOHOSPBSE: 508869Healthcare ServicesLarge Cap
Last close ₹7,730.00up ₹125.50 (1.65%)BSE ₹7,731.95
Share price at the NSE close on 23 Oct 2026. Previous close ₹7,604.50.
52-week range of traded prices to 23 Oct 2026
₹6,696.50Low, 23 Jan 2026₹9,070.50High, 23 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and other business matters.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,11,146 Cr97th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 12 Aug 2026
- 53.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 20 May 2026
- 11.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.26%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- 23.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- 19.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 20 May 2026
- 0.57
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 4,96,46046.0% delivered
Apollo Hospitals Enterprise share news and announcements
864 announcements, routine notices left out, newest first. Page 3 of 18.
Apr 2025
Mar 2025
4 Mar · Business
4 Mar · Business
Feb 2025
10 Feb · Corporate action
10 Feb · Results
10 Feb · Corporate action
10 Feb · Board meeting
Jan 2025
30 Jan · Analysts
Dec 2024
24 Dec · Business
4 Dec · Legal
Exchange has sought clarification from Apollo Hospitals Enterprise Limited for the quarter ended 30-Sep-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not submitted as per Indian Accounting Standard. The response of the Company is awaited.
Nov 2024
6 Nov · Board meeting
1 Nov · Business
Oct 2024
25 Oct · Analysts
Sep 2024
11 Sep · Business
9 Sep · Legal
Exchange has sought clarification from Apollo Hospitals Enterprise Limited for the quarter ended 30-Jun-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.4 Sep · Business
4 Sep · Business
Aug 2024
30 Aug · Updates
19 Aug · Corrigendum
13 Aug · Limited Review Report
13 Aug · Board meeting
5 Aug · Analysts
3 Aug · Dividend
3 Aug · Board meeting
Jul 2024
31 Jul · Board meeting